Prof. Dr. Mehmet Hilmi Doğu

Лимфомы, множественная миелома и плазмоклеточные заболевания; острые и хронические лейкозы.

Хронические миелопролиферативные заболевания, анемии и нарушения свёртывания крови.

1999–2005: Медицинский факультет Университета Ege.

2006–2011: Университет Pamukkale, специализация по внутренним болезням.

2011–2014: Университет Pamukkale, дополнительная специализация по гематологии.

2018: Звание доцента по гематологии, Стамбульская учебно-исследовательская больница.

Liv Hospital Ulus и Bahçeşehir, гематология.

Медицинский факультет Университета İstinye, профессор гематологии.

2020: Başakşehir Çam and Sakura City Hospital, преподаватель гематологии.

2015–2020: Стамбульская учебно-исследовательская больница, гематолог и административный руководитель клиники; преподаватель в 2019–2020.

2015: Больница медицинского факультета Университета Selçuk.

2011: Государственная больница Denizli Sarayköy, специалист по внутренним болезням.

2014: ESCCA Summer School on Cytometry, Прага.

Турецкое общество гематологии; Общество гематологического образования и исследований, член правления.

Culminate 74494550AML2011, ABG002 и наблюдательный регистр эпоэтина альфа при миелодиспластических синдромах: главный исследователь.

PASS-TR, Lumiere C140012, Prefmab M028457 и Green M028543: соисследователь.

2013: Награда молодому исследователю, 39-й Национальный конгресс гематологии.

2013: Награда молодому участнику, 8-й Национальный конгресс афереза.

2014: Поощрительная награда, 9-й Национальный конгресс афереза.

2015: Специальная награда жюри за доклад, 3-й Конгресс гематологической онкологии.

2016: Третье место за доклад, 2-й Симпозиум гематологической онкологии и трансплантации костного мозга.

Kobak S, Dogu MH, Aydogan M, Karakoc ZC, Simsek B. VEXAS Syndrome and IgG4-Related Disease: Coincidental Association or Pathogenetic Link? Mediterr J Rheumatol. 2026;37(1):106–109. DOI: 10.31138/mjr.230126.epr.

Bakirtas M, Yonal Hindilerden I, Uncu Ulu B, Ekinci O, Dogu MH, et al. Outcomes of Brentuximab Vedotin Monotherapy in Refractory/Relapsed Classical Hodgkin’s Lymphoma: A Multi-Center Retrospective Study on Survival and Safety. Indian J Hematol Blood Transfus. 2026;42(3):781–791. DOI: 10.1007/s12288-025-02093-w.

Dogu MH, Batgi H, Erkurt MA, Hacioglu S, Tekgunduz E, Kaya E, Iskender D, Eren R, Kuku I, Altuntas F. Stem cell mobilization kinetics in elderly patients with multiple myeloma.  Transfus Apher Sci. 2018 Apr;57(2):204-207. doi: 10.1016/j.transci.2018.01.010. Epub 2018 Feb 1

Dogu MH, Çagirgan S, Ocakci S, Kaya AH, Ilkkilic K, Sanli NM, Kahraman S, Eren R, Tekgunduz E, Hacioglu S, Kaynar L, Erkurt MA, Altuntas F. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma. Transfus Apher Sci. 2017 Dec;56(6):814-818. doi: 10.1016/j.transci.2017.11.012. Epub 2017 Nov 8.

Dogu MH, Kaya AH, Berber I, Sari İ, Tekgündüz E, Erkurt MA, Iskender D, Kayıkçı Ö, Kuku I, Kaya E, Keskin A, Altuntaş F. Does the preference of peripheral versus central venous access in peripheral blood stem cell collection/yield change stem cell kinetics in autologous stem cell transplantation? Transfus Apher Sci. 2016 Feb;54(1):76-9. doi: 10.1016/j.transci.2016.01.017.

Serin I, Sari ND, Dogu MH, Acikel SD, Babur G, Ulusoy A, Onar MI, Gokce EC, Altunok O, Yaylaci Mert F, Karakilic A, Baltik M, Gulesir B A new parameter in COVID-19 pandemic: initial lactate dehydrogenase (LDH)/Lymphocyte ratio for diagnosis and mortality..J Infect Public Health. 2020 Nov;13(11):1664-1670. doi: 10.1016/j.jiph.2020.09.009. Epub 2020 Sep 30.

Erkurt, M. A., Hindilerden, F., Ekinci, O., Yildiz, J., Dal, M. S., Bagci, M., Hacibekiroglu, T., Dogu, M.H., Namdaroglu, S., Basturk, A., Gulturk, E., Merter, M., Saglam, B., Demircioglu, S., Ozatli, D., Sarici, A., Ulas, T., Korkmaz, S., Eser, B., & Altuntas, F. (2021). An Experience on Pomalidomide in Patients within Relapsed/Refractory Multiple Myeloma - A Multicenter Study in Turkey.Journal of Pharmaceutical Research International, 32(41), 92-98. https://doi.org/10.9734/jpri/2020/v32i4131047

Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Kınık K, Haznedaroglu İ, Yılmaz FM, Kılıç İ, Demircioğlu S, Yosunkaya A, Erkurt MA, Turgut B, Caglayan M, Celik O. Convalescent plasma therapy in patients with COVID-19.Transfus Apher Sci. 2020 Sep 19:102955. doi: 10.1016/j.transci.2020.102955

Altuntas F, Ata N, Yigenoglu TN, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Akunal A, Birinci S; Turkish Ministry of Health, Hematology Scientific Working Group. COVID-19 in hematopoietic cell transplant recipients. Bone Marrow Transplant. 2020 Oct 28. doi: 10.1038/s41409-020-01084-x

Başcı S, Ata N, Altuntaş F, Yiğenoğlu TN, Dal MS, Korkmaz S, Namdaroğlu S, Baştürk A, Hacıbekiroğlu T, Doğu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Çağlayan M, Ayvalı MO, Çelik O, Ülgü MM, Birinci Ş; Turkish Ministry of Health, Hematology Scientific Working Group. Outcome of COVID-19 in patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. J Oncol Pharm Pract. 2020 Aug 27:1078155220953198. doi: 10.1177/1078155220953198.

Yigenoglu TN, Ata N, Altuntas F, Bascı S, Dal MS, Korkmaz S, Namdaroglu S, Basturk A, Hacıbekiroglu T, Dogu MH, Berber İ, Dal K, Erkurt MA, Turgut B, Ulgu MM, Celik O, Imrat E, Birinci S. The outcome of COVID-19 in patients with hematological malignancy. J Med Virol. 2020 Aug 10:10.1002/jmv.26404. doi: 10.1002/jmv.26404.

Eren R, Karışmaz A, Aslan C, Doğu MH, Altındal Ş, Yokuş O, Suyani E.  Beta Thalassemia minor patients: Not tired, but depressed and anxious  Med Princ Pract. 2020 May 27. doi: 10.1159/000508981

Okay M, Aslan T, Özdemir E, Üner A, Sağlam A, Güngör E, Uysal A, Alayvaz Aslan N, Yıldızhan E, Ağıt A, Dal MS, Korkmaz S, Namdaroğlu S, Sivgin S, Akgün Çağlıyan G, Demircioğlu S, Barışta İ, Özhamam E, Vural F, Eser B, Özet G, Yıldırım R, Doğu MH, Berber İ, Erkurt MA, Malkan ÜY, Altuntaş F, Büyükaşık Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor - A Multicenter Cohort Study. Turk J Haematol. 2020 May 6;37(2):84-90. doi: 10.4274/tjh.galenos.2019.2019.0177. Epub 2019 Oct 21.

Eren R, Gündoğan C, Aslan C, Koç A, Doğu MH, Altındal Ş, Yokuş O, Suyanı E, Çermik TF. Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma. Curr Med Imaging Rev. 2020;16(1):59-64. doi: 10.2174/1573405615666190206154847.

Eren R, Karişmaz A, Karataş D, Doğu MH, Altindal Ş, Yokuş O, Suyani E. Comparison of clinical features and survival between young and old chronic lymphocytic leukemia patients: a single center study from Turkey. Leuk Lymphoma. 2019 Mar;60(3):742-747. doi: 10.1080/10428194.2018.1509316. Epub 2018 Sep 6.

Çiftçiler R, Sevindik ÖG, Tekgündüz AİE, Erkurt MA, Vural F, Turgut B, Kaynar L, Payzın B, Doğu MH, Karakuş V, Altuntaş F, Büyükaşık Y, Demirkan F. Acute Lymphoblastic Leukemia in Routine Practice: A Turkish Multicenter Study Turk J Haematol. 2019 Aug 2;36(3):169-177. doi: 10.4274/tjh.galenos.2019.2019.0008. Epub 2019 May 27.

Korkmaz S, Solmaz Medeni S, Demirkan F, Kalayoglu Besisik S, Altay Dadin S, Akgun Cagliyan G, Kabukcu Hacioglu S, Sari I, Goren Sahin D, Arat M, Dagdas S, Ozet G, Kutlu N, Karaagac Akyol T, Ozcebe OI, Uskudar Teke H, Kiper Unal D, Guner N, Tombak A, Celik H, Bay I, Kiki I, Ozgur G, Erkurt MA, Ozatli D, Meletli O, Demircioglu S, Demir C, Kurtoglu E, Vural F, Tobu M, Karakus A, Ayyildiz O, Dal MS, Afacan Ozturk B, Albayrak M, Ocakci S, Bolaman Z, Sonmez M, Karakus V, Gokmen Sevindik O, Berber I, Dogu MH, Gulturk E, Ulas T, Payzin B, Kuku I, Cagirgan S, Altuntas F. The Turkish experience with therapeutic plasma exchange: A national survey. Transfus Apher Sci. 2019 Jun;58(3):287-292. doi: 10.1016/j.transci.2019.04.015. Epub 2019 Apr 23. Review.

Gemici A, Aydogdu I, Terzi H, Sencan M, Aslan A, Kaya AH, Dal MS, Akay MO, Dogu MH, Ayyildiz O, Sahin F, Cagliyan GA, Yilmaz M, Gokgoz Z, Bilen Y, Demir C, Sevindik OG, Korkmaz S, Eser B, Altuntas F; ThREG, Turkish hematology Research and Education Group. Nodular lymphocyte predominant Hodgkin's lymphoma in daily practice: A multicenter experience. Hematol Oncol. 2018 Feb;36(1):116-120. doi: 10.1002/hon.2460. Epub 2017 Jul 14.

Kaya AH, Tekgündüz E, Ilkkiliç K, Dal MS, Merdin A, Karakus A, Hacioglu SK, Bekdemir F, Çakar MK, Dogu MH, Ayyildiz MO, Korkmaz S, Altuntaş F; On the behalf of The Turkish Hematology Research and Edication Group (ThREG). Efficacy of CLARA in recurrent/refractory acute myeloid leukaemia patients unresponsive to FLAG chemotherapy. J Chemother. 2018 Feb;30(1):44-48. doi: 10.1080/1120009X.2017.1396017. Epub 2017 Nov 3.

Beköz H, Karadurmus N, Paydas S, Türker A, Toptas T, Firatli Tuglular T, Sönmez M, Gülbas Z, Tekgündüz E, Kaya AH, Özbalak M, Tastemir N, Kaynar L, Yildirim R, Karadogan I, Arat M, Pepedil Tanrikulu F, Özkocaman V, Abali H, Turgut M, Kurt Yüksel M, Özcan M, Dogu MH, Kabukçu Hacioglu S, Barista I, Demirkaya M, Köseoglu FD, Toprak SK, Yilmaz M, Demirkürek HC, Demirkol O, Ferhanoglu B. Nivolumab for relapsed or refractory Hodgkin lymphoma: real-life experience. Ann Oncol. 2017 Oct 1;28(10):2496-2502. doi: 10.1093/annonc/mdx341.

Eren R, Doğu MH, Emir S, Huq GE, Okçu O, Altındal Ş, Yokuş O, Suyanı E. Rethinking the usefulness of bone marrow biopsy on treatment decision in CLL patients at diagnosis. Ann Hematol. 2017 Aug;96(8):1315-1321. doi: 10.1007/s00277-017-2997-7. Epub 2017 Apr 24.

Korkmaz S, Dal MS, Berber I, Sahin DG, Dogu MH, Ayyildiz O, Nizam I, Albayrak M, Esen R, Namdaroglu S, Sencan M, Akay OM, Hacioglu S, Yildirim R, Eser A, Tombak A, Pala C, Ilhan O. Clinical characteristics and therapeutic outcomes of elderly patients with chronic myeloid leukemia: A retrospective multicenter study. Geriatr Gerontol Int. 2015 Jun;15(6):729-35. doi: 10.1111/ggi.12341.

Erkurt MA, Berber I, Tekgündüz E, Dogu MH, Korkmaz S, Demir C, Yilmaz M, Akay OM, Pala C, Bilen Y, Kaya E, Sari I, Sencan M, Kuku I, Altuntaş F, Dal MS, Aydogdu I. Primary central nervous system lymphoma in daily practice and the role of autologous stem cell transplantation in relapsed disease: A retrospective multicenter study. Transfus Apher Sci. 2016 Feb;54(1):80-4. doi: 10.1016/j.transci.2016.01.018.

Tekgündüz E, Göker H, Kaynar L, Sarı İ, Pala Ç, Doğu MH, Öztürk E, Turgut B, Korkmaz S, Tetik A, Büyükaşık Y, Hacıoğlu SK, Bozdağ SC, Özdemir E, Altuntaş F. Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in Daily Practice: A Multicenter Experience. Clin Lymphoma Myeloma Leuk. 2016 May;16(5):269-74. doi: 10.1016/j.clml.2016.01.007.

Pekel G, Doğu MH, Sarı HI, Acer S, Kasikci A, Yagci R, Çetin EN. Retinal Vessel Caliber, Choroidal Thickness and Ocular Pulse Amplitude Measurements in Essential Thrombocythemia. Middle East Afr J Ophthalmol. 2016 Jan-Mar;23(1):84-8. doi: 10.4103/0974-9233.171827.

Tombak A, Uçar MA, Akdeniz A, Tiftik EN, Gören Şahin D, Akay OM, Yıldırım M, Nevruz O, Kış C, Gürkan E, Solmaz ŞM, Özcan MA, Yıldırım R, Berber İ, Erkurt MA, Fıratlı Tuğlular T, Tarkun P, Yavaşoğlu İ, Doğu MH, Sarı İ, Merter M, Özcan M, Yıldızhan E, Kaynar L, Mehtap Ö, Uysal A, Şahin F, Salim O, Sungur MA. The role of azacitidine in the treatment of elderly patients with AML-results of a retrospective multicenter study. Turk J Haematol. 2016 Apr 18. doi: 10.4274/tjh.2015.0203.

Eren R, Nizam N, Doğu MH, Mercan S, Erdemir AV, Suyanı E. Evaluation of neutrophil-lymphocyte ratio in patients with early-stage mycosis fungoides. Ann Hematol. 2016 Oct;95(11):1853-7. doi: 10.1007/s00277-016-2779-7.

Hacioglu S, Bilen Y, Eser A, Sivgin S, Gurkan E, Yildirim R, Aydogdu I, Dogu MH, Yilmaz M, Kayikci O, Tombak A, Kuku I, Celebi H, Akay MO, Esen R, Korkmaz S, Keskin A. Multicenter retrospective analysis regarding the clinical manifestations and treatment results in patients with hairy cell leukemia: twenty-four year Turkish experience in cladribine therapy. Hematol Oncol. 2015 Dec;33(4):192-8. doi: 10.1002/hon.2177. Epub 2014 Nov 13.

Barış İC, Caner V, Şen Türk N, Sarı İ, Hacıoğlu S, Doğu MH, Çetin O, Tepeli E, Can Ö, Bağcı G, Keskin A. Possible Role of GADD45γ Methylation in Diffuse Large B-Cell Lymphoma: Does It Affect the Progression and Tissue Involvement? Turk J Haematol. 2015 Dec;32(4):295-303. doi: 10.4274/tjh.2014.0174.

Caner V, Sen Turk N, Baris IC, Cetin GO, Tepeli E, Hacioglu S, Sari I, Zencir S, Dogu MH, Bagci G, Keskin A. MYD88 expression and L265P mutation in mature B-cell non-Hodgkin lymphomas. Genet Test Mol Biomarkers. 2015 Jul;19(7):372-8. doi: 10.1089/gtmb.2015.0041.

Pekel G, Doğu MH, Keskin A, Acer S, Yağcı R, Kaşıkçı A, Çetin EN. Subfoveal Choroidal Thickness Is Associated with Blood Hematocrit Level. Ophthalmologica. 2015;234(1):55-9. doi: 10.1159/000433449.

Ilhami Berber, Erkurt MA, Muzaffer Keklik, Dogu MH, Hatice Terzi, Cigdem Pala, Sarı HI,  Mehmet Sencan, Sıvgın S, Hacıoglu S, Fevzi Altuntas, Aydogdu I,  Osman Ilhan  Clinical characteristics, post-treatment assessment and prognostic factors affecting patient survival of patients at 65 years of age or older with hodgkin lymphoma: A retrospective multicenter study from Turkey  Acta Medica Mediterranea 2015 31(6):907-914

Hacıoğlu S, Sarı I, Doğu MH, Keskin A.The effect of gradual increment in rhG-CSF dose on stem cell yields in patients with multiple myeloma mobilized with intermediate dose cyclophosphamide plus rhG-CSF. Transfus Apher Sci. 2014 Feb;50(1):71-4. doi: 10.1016/j.transci.2013.11.003.

Kaya E, Keklik M, Sencan M, Yilmaz M, Keskin A, Kiki I, Erkurt MA, Sivgin S, Korkmaz S, Okan V, Doğu MH, Unal A, Cetin M, Altuntaş F, Ilhan O.Therapeutic plasma exchange in patients with neurological diseases: multicenter retrospective analysis. Transfus Apher Sci. 2013 Jun;48(3):349-52. doi: 10.1016/j.transci.2013.04.015.

Sari I, Arslan A, Ozlu C, Hacioglu S, Dogu MH, Isler K, Keskin A. The effect of pneumatic tube system on complete blood count parameters and thrombocyte donation in healthy donors.Transfus Apher Sci. 2012 Aug;47(1):81-3. doi: 10.1016/j.transci.2012.05.005

Topsakal S, Akin F, Yerlikaya E, Erurker T, Dogu H. Dehydroepiandrosterone sulfate levels in Turkish obese patients. Eat Weight Disord. 2014 Jun;19(2):261-5. doi: 10.1007/s40519-014-0120-9 Epub 2014 Apr 9.

Dogu MH, Hacıolu S. Analysis of plateletpheresis donor deferral rate, Characteristics, and its preventability. J Appl Hematol 2017;8(1), 12-5. doi:10.4103/joah.joah_6_17

Dogu MH, Hacıoglu S, Sarı I, Keskin A. Changes in Serologic Markers of Hepatitis B in Autologous Hematopoietic Stem Cell Transplantation Recipients. J Appl Hematol 2016;7:30-34.

Ayaz A, Tepeli E, Sarı I, Çetin O, Eser M, Dogu H, Bagcı G. Contribution of MLPA to routine testing to detect the prognostic chromosomal abnormalities in chronic lymphocytic leukemia. Gene Ther Biol 2014;16:1-9

Dogu MH, Hacioglu S. Can vısual analogue scala (vas) be used in pain determination and palliation in multiple myeloma patients ? International Journal of Current Multidisciplinary Studies April, 2017 Vol. 3, Issue,04, pp.719-720,

Yokuş O, Dogu MH, Aydinli F, Eren R, Altindal S et al. (2017) Vitamin D Deficiency and its Effects on Patients with Multiple Myeloma. Hematol Transfus Int J 5(2): 00112. DOI: 10.15406/htij.2017.05.00112

Dogu MH, Serın I, Suyani E. Two Chronic Myeloid Leukemia Patients Presenting with Isolated Thrombocytosis International Journal of Innovative Research in Medical Science (IJIRMS)Vol. 5 No. 08 (2020) | Page No.: 353 - 355 | https://doi.org/10.23958/ijirms/vol05-i08/938

Dogu MH, Sari I, Hacioglu S, Degirmencioglu S, Şen N, Keskin A. Two rare diagnoses during chronic lymphocytic leukaemia follow-up: Kaposi's sarcoma and Merkel cell carcinoma. Scott Med J. 2016 Jun 22. pii: 0036933015619590.

Dogu MH, Sarı I, Hacıoglu S, Keskin A. Dramatic Response in the dependency to transfusion after low doses of lenalidomide treatment in a 5q-syndrome patient: a case report. North Clin Istanbul 2014;1(3):191-193

Dogu MH, Sarı I, Hacıoglu S, Keskin A. Cutaneous Adverse Effects of Imatinib Mesylate. North Clin Istanbul 2014;1(3):173.

Dogu MH, Nizam N, Eren R, Suyani E.  Is it Brucellosis or Multiple Myeloma? Or can it be both? Journal of Hematology & Multiple Myeloma 2016(1);1:1-3.

Dogu MH, Sarı I, Hacıoglu S, SEN N, Keskin A. Isolated Palatal Perforation Due to Mucormycosis in A Patient with Acute Myeloid Leukemia.  International Journal of Advances In Case Reports, 2016;3(4):193-195.

Dogu MH, Sarı I, Hacıoglu S, Keskin A Unusual Response to Eltrombopag and Dose Adjustment in Patient with Diagnosis of Refractory Immune Thrombocytopenia .  International Journal of Advances In Case Reports, 2016;3(3):117-119.

Serin I, Dogu MH. An unexpected situation in isolated nasopharyngeal mass differential diagnosis: Solitary extramedullary plasmacytoma. Otolaryngology Case Reports 17(11):100246. doi.org/10.1016/j.xocr.2020.100246

Serin I, Ulusoy A, Onar MI, Dogu MH Recurrence of lymphoma with isolated pericardial mass: a case report..J Med Case Rep. 2020 Oct 3;14(1):175. doi: 10.1186/s13256-020-02508-4

Serin I, Eren R, Dogu MH. Lenalidomide Plus Decitabine Treatment in a Myelodysplastic Syndrome Patient With Deletion 5q and Excess Blasts. J Hematol. 2020 Apr;9(1-2):33-36. doi: 10.14740/jh618. Epub 2020 Apr 23.

Karismaz A, Dogu MH, Huq G, Altindal S, Yokus O, Suyani E. A diffuse large B cell lymphoma emerging with breast cancer relapse. Pan Afr Med J. 2018 Oct 19;31:125. doi: 10.11604/pamj.2018.31.125.15057. eCollection 2018.

Hacıoğlu SK, Doğu MH, Sarı İ, Keskin A.  Successful Treatment of Refractory Gastrointestinal Bleeding by Systemic (Oral) Ankaferd Blood Stopper in a Patient with Glanzmann Thrombasthenia. Balkan Med J. 2015 Apr;32(2):218-20. doi: 10.5152/ balkanmedj.2015.15734.

Kantarci FE, Eren R, Gündoğan C, Huq GE, Doğu MH, Suyanı E. A HHV-8 positive, HIV negative multicentric Castleman disease treated with R-CEOP chemotherapy and valganciclovir combination. J Infect Chemother. 2016 Mar 2. pii: S1341-321X(16)00022-2. doi: 10.1016/j.jiac.2016.01.002.

Eren R, Aslan C, Gündoğan C, Yokuş O, Doğu MH, Suyanı E. A primary bone diffuse large B cell lymphoma with ocular adnexal involvement. Turk J Haematol. 2016 Apr 18. doi: 10.4274/tjh.2015.0424

Eren R, Aslan C, Yokuş O, Doğu MH, Suyani E. T-cell acute lymphoblastic leukemia with co-expression of CD56, CD34, CD117 and CD33: A case with poor prognosis. Mol Clin Oncol. 2016 Aug;5(2):331-332.

Eren R, Aydınlı F, Yokuş O, Aslan C, Gündoğan C, Doğu MH, Suyanı E, Altındal S, Gedik H. A Disseminated Myeloid Sarcoma Case Transformed into Leukemia Glob J Med Res Volume 17 Issue 3 Version 1.0 Year 2017 Online ISSN: 2249-4618 & Print ISSN: 0975-5888

Dogu MH, Sarı I, Ertürk S, Hacıoglu S, Keskin A. Aferez Trombosit Donasyonu: Demografik bulgular, işlem ve ürün özellikleri. Pamukkale Medical Journal 2015;8(1):19-22.

Dogu MH, Hacıoglu S. Antitrombosit Ajanlar Turkiye Klinikleri J Hematol-Special Topics 2016;9(4):76-80

Dogu MH, Sarı I. Myelodisplastik/Myeloproliferatif Displaziler. Turkiye Klinikleri J Hematol-Special Topics 2016;9(2):48-51

Dogu MH, Sarı I. Hemorajik Diyatezde Hemostatik Ajan Kullanımı. Turkiye Klinikleri J Hematol-Special Topics 2015;8(2):82-84.

Dogu MH, Sarı I. Hemolitik Anemilerin Tanısı ve Laboratuvar Yöntemlerinin Doğru Kullanımı. Turkiye Klinikleri J Hematol-Special Topics 2012;5(4):48-51

Dogu MH, Sarı I. Yeni Tedavi Alternatifleri. Turkiye Klinikleri J Hematol-Special Topics 2012;5(3):66-74.

Doğu MH,  Kabukcu Hacıoğlu S. Alternatif Bir Tedavi Seçeneği Terapötik Aferez Tanı ve Klinik Bazlı Yaklaşım 5 Yıllık Deneyim ACTA ONCOLOGICA TURCICA 50 (3), 218-223 DOI: 10.5505/aot.2017.86158

Dogu MH, Serin I . COVID-19 Enfeksiyonunda Gelişmekte Olan Tedaviler Kulak Burun Boğaz ve COVID-19. 1. Baskı. Ankara: Türkiye Klinikleri; 2020. p.91-5.

Serin I, Dogu MH, Cavdar VC. Suyanı E. Evaluation of the Relationship Between Initial Lymphocyte Count and Molecular Response to Imatinib Therapy in Chronic Myeloid Leukaemia Patients. İstanbul Med J 2020; 21(6): 473-476. DOI: 10.4274/imj.galenos.2020.46690

Serin I, Dogu MH. Subgroup Analysis in Multiple Myeloma Patients under Sixty Years: A Single-Center Study. İstanbul Med J 2021; 22(1): 73-7 DOI: 10.4274/imj.galenos.2021.62593

Serin I, Dogu MH. Subgroup Analysis in Multiple Myeloma Patients under Sixty Years: A Single-Center Study. İstanbul Med J 2021; 22(1): 73-7. DOI: 10.4274/imj.galenos.2021.62593

Aslan C, Eren R,  Dogu MH, Yokus O, Suyanı E.   Foliküler Lenfoma Tanısı ile Takip Edilen Hastalarda Nötrofil-Lenfosit Oranının Klinikopatolojik Parametreler ile İlişkisi Istanbul Med J 2016; 17: 150-151 DOI: 10.5152/imj.2016.93546

Eren R, Dogu MH, Koc A, Altındal Ş, Yokus O, Suyanı E. The association of mean platelet volume and platecrit and bone marrow fibrosis in patients with essential thrombocythemia: a cohort study. J surg med. 2019; 3(2): 176-179. doi.org/10.28982/josam.525751

Sarı ND, İnci A, Dogu MH, Yoruk G. Evaluation of Hepatitis B Virus Serology, Antiviral Use and Reactivation Hepatitis in Hematologic Malignancy Patients Turkiye Klinikleri J Med Sci. 2020;40(1):74-8 doi: 10.5336/medsci.2019-71432

Terzi H, Korkmaz S, Berber I, Keklik M, Dogu MH, Sencan M, Kaya E, Eser B, SARI I, Ilhan O. Clinical Characteristics and Treatments Outcomes in Elderly Patients with Multiple Myeloma: A Multicenter Retrospective Study. Cumhuriyet Medical Journal, 39(1), 389-389. Doi: 10.7197/cmj.v39i1.5000200133

Eren R, Özdemir Ö, Aslan C, Dogu MH, Altındal S, Yokus O, Suyanı E. The association of globulin levels with treatment response and survival in multiple myeloma patients. Eurasian Journal of Medicine and Oncology, Doi: 10.14744/ejmo.2017.63835

R Eren, MH Dogu, Ş Altındal, O Yokus, E Suyani. The seasonality in the diagnosis of acute leukemia: A single center data from Turkey. Marmara Medical Journal 2018; 31: 112-115  DOI: 10.5472/marumj.474176

Dogu MH, Hacıoglu S, Sarı I, Keskin A. İmmun Trombositopeni Tedavisinde Kullanılan Bir İlaç Olan Eltrombopag Pseudotrombositopeni Nedeni Olabilir mi? Olgu Sunumu.  Pamukkale Medical Journal 2014;7(1):83-85.

Dogu MH, Keskin A. Siklik Trombositopeni ve MYH-9 İlişkili Trombosit Hastalıkları (Yazarın Yanıtı). Pamukkale Medical Journal 2014;7(2):175.

Dogu MH, Sarı I, Hacıoglu S, Ertürk S, Keskin A.. Herediter Hemorajik Telenjiektazi Olgusunda Sistemik Bevacizumab Tedavisine Dramatik Yanıt. J Turgut Ozal Med Cent 2015;22(4):269-271.

Dogu MH, Sarı I, Ertürk S, Hacıoglu S, Keskin A. Olagan dısı Ekstranodal Tutulumlarla Agresif Seyreden Mantle Hücreli Lenfoma. Selçuk Tıp Dergisi, 2016;32(1), 27-29.

Serın I, Dogu MH Göze H, Muglu H, Yokus O. A Rare Disease in the Differential Diagnosis of Chylothorax: Waldenström’s Macroglobulinaemia. İstanbul Med J 2020; 21(Suppl 1): 17-19. DOI: 10.4274/imj.galenos.2020.56750

Sahin B, Karabulut A, Demirtas O, Dogu MH. Gebelikte Nadir Görülen Bir Kanama Bozukluğu: Geç Tanı Alan Faktör VII Eksikliği. Turkiye Klinikleri J Gynecol Obst 2015;25(3):221-223.

Altunoğlu E, Celik DC, Hekimoğlu S, Özsoy E, Dogu MH.  Fever of Unknown Origin: A Patient with Intermittent Idiopathic Fever for Three Years. İstanbul Med J 2020; 21(Suppl 1): 23-25. DOI: 10.4274/imj.galenos.2020.71084

Özlem Önerci Çelebi, Enes Yiğit, Mehmet Hilmi Doğu. Baş Boyun Lenfomaları. Kulak Burun Boğaz ve Baş Boyun Cerrahisi Uzmanlık Eğitimi Kaynak Kitap 2019; 2. Cilt 414-426. (Logos Yayıncılık)

Sinem Namdaroğlu, Mehmet Hilmi Doğu. Kan ve Kan Ürünlerini Tanıma. Bütüncül Tıp Aile Hekimliğinde Güncel Tanı ve Tedavi. Dahili Branşlar Hematoloji Bölüm 24 1282-1284

Rafet Eren, Mehmet Hilmi Doğu. Transfüzyon Reaksiyonları. Bütüncül Tıp Aile Hekimliğinde Güncel Tanı ve Tedavi. Dahili Branşlar Hematoloji Bölüm 25 1285-1286

Dogu MH, Keklık M,Terzı H,Korkmaz S,Erkurt MA,Akgün Çaglıyan G,Kaynar L,Sıvgın S,Sarı I,Keskın A,Sencan M, Altuntas F, Ilhan O. Diffuse Large B-Cell Lymphoma in adults aged 65 years and older: A retrospective multicenter analysis of clinical characteristics and therapeutic outcomes. SOHO 2015 Annual Meeting, Doi: 10.1016/j.clml.2015.04.091 (Özet Bildiri/Poster)(Yayın No:3834187)

Dogu MH, Eren R, Suyanı E (2017). Lenalidomide Plus Decitabine Treatment in a Del5Q Patient with RAEB-1 and Response in the Dependency to Transfusion and Blast Ratio. 14th International Symposium on Myelodysplastic Syndromes (MDS), Doi: 10.1016/S0145- 2126(17)30212-6 (Özet Bildiri/Poster)(Yayın No:3834157)

Hacıoglu S, Dogu MH, Sarı I, Keskın A (2014). Autoimmune Manifestation in Myelodysplastic Syndrome. V. International Eurasian Hematology Congress, 38, 37, Doi: 10.1016/S0145-2126(14)70084-0 (Özet Bildiri/Poster)(Yayın No:3834268

Keklık M, Dogu MH,Nızam I, Terzı H, Hacıoglu S, Erkurt MA, Keskın A, Eser B, Çetın M, Ünal A, Ilhan O (2014). Management Of Mantle Cell Lymphoma In The Elderly: A Retrospectıve Multıcenter Study. V. International Eurasian Hematology Congress, Doi: 10.1016/S0145-2126(14)70060-8 (Özet Bildiri/Poster)(Yayın No:3834250)

Sevındık OG, Solmaz S, Pehlıvan M, Kavukçu S, Yalnız FF, Özkocaman V, Arat M, Turgut M, Özcan M, Özsan GH, Aslan Ö, Sönmez M, Aydın Y, Dogu Mehmet Hılmı (2017). Realworld Data In Relapsed Refractorymyeloma Patıents Treated Wıth Carfılzomıb,A Multıcenter Turkısh Experıence. 6th International Congress on Leukemia Lymphoma Myeloma (Özet Bildiri/Poster)(Yayın No:4888873)